FDA approves first-of-its-kind nasal spray for severe depression
This treatment is delivered through a nasal spray and relies not on ketamine, but one of its two primary components called esketamine. The end result, Spravato has since been approved in 77 ...
FDA Approves Nasal Spray for Depression - Newsweek
1 day ago · This new treatment could help bring relief for millions of Americans struggling with depression. What To Know. The nasal spray Spravato, which is made from the drug esketamine, had been approved ...
FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression
1 day ago · Spravato nasal spray is administered by the patient under the supervision of a health care provider in a health care setting. Spravato targets the neurotransmitter glutamate; however, the mechanism by which esketamine exerts its antidepressant effect is unknown. ... "Treatment-resistant depression can be very complicated, especially for ...
FDA approves Spravato, first monotherapy nasal spray to treat
2 days ago · The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive ...
Ketamine Nasal Spray Approved as Standalone Treatment for …
20 hours ago · An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato ...
SPRAVATO® (esketamine): A Prescription Nasal Spray
SPRAVATO®, the only FDA-approved nasal spray for adults with treatment-resistant depression, reduces depression symptoms when two or more oral antidepressants haven't worked. SPRAVATO® can be taken with or without an oral antidepressant.
FDA approves new nasal spray medication for treatment-resistant ...
The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have tried...
Spravato Nasal Spray: Uses, Dosage, Side Effects - Drugs.com
Aug 23, 2023 · Spravato (esketamine) nasal spray is used for treatment-resistant depression and major depressive disorder (MDD) with acute suicidal ideation or behavior. Includes Spravato side effects, interactions and indications.
Esketamine for Treatment-Resistant Depression - Johns Hopkins Medicine
Esketamine is made from a drug called ketamine, an anesthetic that has also been used for many years to treat depression. But it wasn’t until recently that esketamine, a more potent version of ketamine, earned FDA approval specifically for use as a nasal spray for those with treatment-resistant depression.
J&J ketamine-derived nasal spray approved to treat depression
1 day ago · The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...